Actos Class Action Lawsuit – Free Case Evaluation
Actos class action lawsuits are nothing new. The popular diabates drug was investigated last Fall by the FDA to check for possible links to bladder cancer. This Spring, studies were published linking Actos side effects to increased risk of bladder cancer. Health officials in France and Germany issued an Actos recall recently, although in those countries it’s less of an Actos recall and more of a suspension of sales of Actos.
The Actos recall in European countries was initiated after an insurance study revealed an increased risk of bladder cancer in patients taking Actos. In the study released last month, patients who took Actos for a year or more had more risk of contracting bladder cancer. The study occurred over a ten year period and was conducted by Takeda Pharmaceuticals, makers of Actos.
The FDA will now be reviewing Actos for bladder cancer risk. It’s a safety review and could result in an Actos recall. Actos is of the same drug class as Avandia. Avandia, which is a competitor to Actos, has been linked to increased risk of heart attacks. Avandia is closer in the medical/legal processes to actually being recalled, which makes more doctors prescribe Actos, which is an alternative drug for treatment of Type 2 Diabetes.
